Abstract
Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 103-110 |
| Number of pages | 8 |
| Journal | Critical Pathways in Cardiology |
| Volume | 7 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2008 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Acute heart failure treatment. / Kirk, James D; Filippatos, Gerasimos; Gheorghiade, Mihai; Pang, Peter S.; Levy, Phillip; Amsterdam, Ezra A; Peacock, W. Frank; Fonarow, Gregg C.
In: Critical Pathways in Cardiology, Vol. 7, No. 2, 06.2008, p. 103-110.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Acute heart failure treatment
AU - Kirk, James D
AU - Filippatos, Gerasimos
AU - Gheorghiade, Mihai
AU - Pang, Peter S.
AU - Levy, Phillip
AU - Amsterdam, Ezra A
AU - Peacock, W. Frank
AU - Fonarow, Gregg C.
PY - 2008/6
Y1 - 2008/6
N2 - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.
AB - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.
UR - http://www.scopus.com/inward/record.url?scp=67650118200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650118200&partnerID=8YFLogxK
U2 - 10.1097/HPC.0b013e318177df37
DO - 10.1097/HPC.0b013e318177df37
M3 - Article
AN - SCOPUS:67650118200
VL - 7
SP - 103
EP - 110
JO - Critical Pathways in Cardiology
JF - Critical Pathways in Cardiology
SN - 1535-282X
IS - 2
ER -